Turning Point 2013
A selection of articles from the 2013 issue of Turning Point.
Download this issue for your iPad from iTunes
To see the entire publication, please download the PDF version. If you'd like to receive a print version of Turning Point in the mail, please complete this form.
Tarceva, a targeted therapy used to treat some types of non-small cell lung cancers, is showing promise in treating vulvar cancer in a recent Dana-Farber clinical trial.
Researchers at Dana-Farber look at the ways certain breast and ovarian cancers have similar gene mutations and shared treatments.
Tissue samples donated by patients are among medical researchers' most precious resources.
Breast cancer survivor Amy Tull Atwood describes her decision to donate tissue for research.
Using human tissue samples has helped researchers develop effective treatments for many breast and gynecologic cancers.
Turning Point is published for supporters of Dana-Farber's Susan F. Smith Center for Women's Cancers. To learn more about the Susan Smith Center and its offerings, call Administrative Director Candace S. Lowe, ScD, at 617-632-2675.
Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:
Dana-Farber Cancer Institute
Department of Communications
450 Brookline Ave.
Boston, MA 02115